l carnitine andrew huberman Developing a Rational Approach to Supplementation for Health & Performance huberman acetyl l carnitine andrew

In one embodiment, the invention provides methods of treating diseases and/or pathology caused by or characterized by the development or presence of Lewy bodies

59 , 60 , 61 , 62 The reversible oxidative modifications of cysteine residues imply an important mechanism whereby ROS and RNS can readily interact with these molecules, dictating protein function and cell signaling that can be regulated by GSH

The peptides are beginning their work at the cellular and molecular level, upregulating gene expression and initiating repair cascades that will manifest visibly later

The constituent amino acids can then be transported to the muscle (Figure 1)